Annexin Pharmaceuticals AB (publ) (STO: ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.530
-0.024 (-4.33%)
Sep 2, 2024, 11:26 AM CET

ANNX Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-2.94-6.45-17.06-23.32-25.47-14.79
Upgrade
Depreciation & Amortization
0.80.390.390.390.180.22
Upgrade
Other Amortization
5.445.444.533.773.062.68
Upgrade
Asset Writedown & Restructuring Costs
----0-
Upgrade
Other Operating Activities
0.180.18-0-0.02-2.42
Upgrade
Change in Accounts Receivable
-5.52-5.522.346.74-7.92-4.84
Upgrade
Change in Other Net Operating Assets
10.275.96-0.7-2.589.036.57
Upgrade
Operating Cash Flow
8.23-0.01-10.5-15-21.1-12.4
Upgrade
Capital Expenditures
-----1.44-
Upgrade
Divestitures
-----1.96
Upgrade
Sale (Purchase) of Intangibles
-7.27-7.27-8.12-6.36-4.7-2.91
Upgrade
Other Investing Activities
0.25-----1.36
Upgrade
Investing Cash Flow
-7.02-7.27-8.12-6.36-6.14-2.3
Upgrade
Long-Term Debt Issued
-----0.9
Upgrade
Net Debt Issued (Repaid)
-----0.9
Upgrade
Issuance of Common Stock
--26.0838.6422.6-
Upgrade
Other Financing Activities
0.230.090.89-0.5-0.450.24
Upgrade
Financing Cash Flow
0.230.0926.9738.1422.151.14
Upgrade
Net Cash Flow
1.43-7.28.3516.78-5.1-13.57
Upgrade
Free Cash Flow
8.23-0.01-10.5-15-22.54-12.4
Upgrade
Free Cash Flow Margin
13.15%-0.02%-23.54%-44.64%-85.69%-47.92%
Upgrade
Free Cash Flow Per Share
0.21-0.00-0.30-0.54-0.93-0.53
Upgrade
Cash Interest Paid
---0.080.220.1
Upgrade
Cash Income Tax Paid
---0.03--0.47
Upgrade
Levered Free Cash Flow
1.74-5.11-12.25-12.62-17.64-11.59
Upgrade
Unlevered Free Cash Flow
1.74-5.11-12.17-12.57-17.5-11.53
Upgrade
Change in Net Working Capital
-4.77-0.53-1.58-4.16-1.181.05
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.